...
首页> 外文期刊>Analytical and bioanalytical chemistry >Development of an on-line automated sample clean-up method and liquid chromatography-tandem mass spectrometry analysis: application in an in vitro proteolytic assay
【24h】

Development of an on-line automated sample clean-up method and liquid chromatography-tandem mass spectrometry analysis: application in an in vitro proteolytic assay

机译:在线自动样品净化方法和液相色谱-串联质谱分析的开发:在体外蛋白水解测定中的应用

获取原文
获取原文并翻译 | 示例
           

摘要

Fluorescence detection has been a method of choice in industry for screening assays, including identification of enzyme inhibitors, owing to its high-throughput capabilities, excellent reproducibility, and sensitivity. Occasionally, inhibitors are identified that challenge the fluorescence assay limit, necessitating the development of more sensitive detection methods to assess these compounds. For data mining purposes, however, original assay conditions may be required. A direct method transfer to highly sensitive and specific LC-MS-based methods has not always been possible due to the presence of MS-incompatible neutral detergents and non-volatile salts in the assay matrix. Utilizing an in vitro proteolytic screening assay for the serine protease hepatitis C virus (HCV) nonstructural (NS) 3 protease as a test case, we report the development of an automated sample clean-up procedure implemented on-line with liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis to complement fluorescence detection. Ion exchange and peptide microtraps were employed to remove MS-incompatible assay matrix components. Three protease inhibitors were used to validate the MS/MS method. Comparable potencies were achieved for these compounds when assessed by fluorescence and MS/MS detection. Furthermore, four-fold less enzyme could be utilized when employing the MS/MS method compared to fluorescence detection. The longer analysis time, however, resulted in reduced sample capacity. The potency of our designed HCV NS3 protease inhibitors are thus routinely evaluated using a continuous fluorescence-based assay. Only pertinent inhibitors approaching the fluorescence assay sensitivity limit are subsequently analyzed further by LC-MS/MS. This methodology allows us to maintain a database and to compare results independent of the detection method. Despite the relatively slow sample turnaround time of this LC-MS approach, the versatility of the automated on-line clean-up procedure and sample analysis can be applied to assays containing reagents which were historically considered to be MS incompatible.
机译:荧光检测由于其高通量的能力,出色的重现性和灵敏度,已成为筛选分析行业的一种选择方法,包括酶抑制剂的鉴定。有时会鉴定出挑战荧光分析极限的抑制剂,因此有必要开发出更灵敏的检测方法来评估这些化合物。但是,出于数据挖掘的目的,可能需要原始分析条件。由于测定基质中存在MS不相容的中性去污剂和非挥发性盐,因此并非总是可能直接将方法转移到高灵敏度和基于LC-MS的特定方法。利用体外蛋白水解筛选测定丝氨酸蛋白酶丙型肝炎病毒(HCV)非结构性(NS)3蛋白酶作为测试案例,我们报告了在液相色谱-串联质谱在线实施的自动样品净化程序的发展光谱分析(LC-MS / MS)分析以补充荧光检测。离子交换和肽微阱用于去除MS不相容的测定基质成分。三种蛋白酶抑制剂用于验证MS / MS方法。当通过荧光和MS / MS检测评估时,这些化合物的效价相当。此外,与荧光检测相比,采用MS / MS方法时可利用的酶少四倍。但是,较长的分析时间导致样品容量降低。因此,我们使用连续的基于荧光的分析方法常规评估了我们设计的HCV NS3蛋白酶抑制剂的效能。随后仅通过LC-MS / MS进一步分析接近荧光测定灵敏度极限的相关抑制剂。这种方法使我们可以维护数据库并比较独立于检测方法的结果。尽管此LC-MS方法的样品周转时间相对较慢,但自动在线清洁程序和样品分析的多功能性仍可应用于包含历史上被认为与MS不兼容的试剂的分析中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号